Product
Milestone 3: Targeted chemotherapy
1 clinical trial
1 indication
Indication
Pancreatic adenocarcinomaClinical trial
A Prospective Phase II Trial of Molecular Profiling to Guide Neoadjuvant Therapy for Resectable and Borderline Resectable Adenocarcinoma of the PancreasStatus: Completed, Estimated PCD: 2018-06-01